In Senegal, health care is inaccessible for most rural communities. In a country where 54 percent of people live in poverty, this means that preventable illnesses and deaths are all too frequent, especially among the most vulnerable: children.
To help stop the spread of diseases, we teach prevention and treat those who are infected. One way we do this is through Health Huts, which serve as vital hubs for learning and living and are run by trained community volunteers. Health huts improve family health and community health by targeting areas and practices that have a crucial impact on public health: mother, child and newborn health; family planning; fight against illness; community-based malaria control with focused interventions; and information education for health behavioral change.
In its support for this work, ChildFund has amassed significant experience managing donor-funded health projects in Senegal. In 1998, ChildFund Senegal began a nutrition program funded by USAID/Washington that was extended until 2006; in 2003-06, USAID/Senegal funded ChildFund Senegal to conduct a malaria and TB program; and in 2006, ChildFund Senegal was awarded $12.8 million by USAID to lead a consortium of four international organizations for a five-year Community Health Project (PSSC). In 2007, ChildFund Senegal was asked to extend the consortium to include six organizations to implement a $7.8 million President’s Malaria Initiative program in five regions as an adjunct to the original PSSC grant. Most recently, ChildFund won a $40 million grant to extend this work and expand access to health care throughout Senegal.
ChildFund Senegal is also currently the lead executing agent for the Programme de Renforcement de la Nutrition (PRN), a nutrition program funded by the government of Senegal and the World Bank in 10 districts, and an implementing partner on a USAID/OFDA-funded food security project. In addition, ChildFund Senegal is working alongside Catholic Relief Services on the Water Resources Integrated Management Program funded by OMVS to reduce the morbidity and mortality associated with malaria and other diseases.